ulcerative


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

ul·cer·ate

 (ŭl′sə-rāt′)
v. ul·cer·at·ed, ul·cer·at·ing, ul·cer·ates
v.intr.
To develop an ulcer; become ulcerous.
v.tr.
To cause ulceration of.
ul′cer·a′tive (-sə-rā′tĭv, -sər-ə-tĭv) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

ulcerative

(ˈʌlsərətɪv)
adj
(Pathology) of, relating to, or characterized by ulceration: ulcerative colitis.
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

ul•cer•a•tive

(ˈʌl səˌreɪ tɪv, -sər ə tɪv)

adj.
1. causing ulceration.
2. of the nature of or affected with ulceration.
[1565–75; < Medieval Latin]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.ulcerative - of or relating to or characterized by ulceration; "ulcerative colitis"
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

ul·cer·a·tive

a. ulcerativo-a, rel. a una úlcera o caracterizado-a por una condición ulcerosa;
___ colitis → colitis ___.
English-Spanish Medical Dictionary © Farlex 2012
Mentioned in ?
References in periodicals archive ?
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Commission has approved the expanded use of ustekinumab for the treatment of adults with moderately to severely active ulcerative colitis, who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies.
European Commission approves expanded use of Janssen's Stelara
ENPNewswire-August 28, 2019--InDex Pharmaceuticals meets primary endpoint in the phase IIb study CONDUCT with cobitolimod in ulcerative colitis
InDex Pharmaceuticals meets primary endpoint in the phase IIb study CONDUCT with cobitolimod in ulcerative colitis
FRIDAY, July 26, 2019 (HealthDay News) -- New warnings about an increased risk of thrombosis and of death among ulcerative colitis patients taking the 10 mg twice daily dose of the drug tofacitinib (Xeljanz, Xeljanz XR) have been issued by the U.S.
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib; Increased risk seen with 10 mg dose of tofacitinib used for treating ulcerative colitis
INFLAMMATORY bowel disease (IBD) is a term mainly used to describe two conditions: ulcerative colitis and Crohn's disease.
What is inflammatory bowel disease (IBD)?
Global Banking News-June 26, 2019-InDex Pharmaceuticals admits last patient in Phase IIb Study CONDUCT evaluating cobitolimod for ulcerative colitis
InDex Pharmaceuticals admits last patient in Phase IIb Study CONDUCT evaluating cobitolimod for ulcerative colitis
M2 PHARMA-June 26, 2019-InDex Pharmaceuticals admits last patient in Phase IIb Study CONDUCT evaluating cobitolimod for ulcerative colitis
InDex Pharmaceuticals admits last patient in Phase IIb Study CONDUCT evaluating cobitolimod for ulcerative colitis
M2 EQUITYBITES-June 26, 2019-InDex Pharmaceuticals admits last patient in Phase IIb Study CONDUCT evaluating cobitolimod for ulcerative colitis
InDex Pharmaceuticals admits last patient in Phase IIb Study CONDUCT evaluating cobitolimod for ulcerative colitis
The investigators retrospectively studied 3,517 individuals with Crohn's disease and 5,349 patients with ulcerative colitis from ResearchOne, a primary care electronic health records database that covers about 10% of patients in England.
Opioids linked to mortality in inflammatory bowel disease
Among patients with moderate to severe ulcerative colitis, a median of 1.4 years and up to 4.4 years of tofacitinib therapy was safe apart from a dose-related increase in risk of herpes zoster infection, according to an integrated analysis of data from five clinical trials.
Tofacitinib raised herpes zoster risk in ulcerative colitis
[USA], May 9 (ANI): A recent study has revealed that individuals who suffered from inflammatory bowel disease including ulcerative colitis and Crohn's disease during childhood are at an increased risk of cancer and early death.
Inflammatory bowel disease during childhood linked to higher cancer rates: Study

Dictionary browser ?
Full browser ?